48 / 74
46
J. Melo T. et al.
Correspondencia a:
Dr. Joel Melo T.
Centro de Enfermedades Respiratorias Clínica Las Con-
des. Centro de Trasplante Clínica Las Condes.
Programa de Trasplante Instituto Nacional del Tórax.
Santiago, Chile.
Email:
joelmelot@hotmail.com19.- Englum B R, Ganapathi A M, Speicher P J,
Gulack B C, Snyder L D, Davis D. Impact of
donor and recipients hepatitis C Status in Lung trans-
plantation J Heart Lung Transplant 2016; 35: 228-35.
20.- Manickam P, Krishnamoorthi R, Kanaan
Z, Gunasekaran P K, Cappell M S. Prognostic
implications of recipients or donor hepatitis B sero-
positivity in thoracic transplantation: analysis of 426
hepatitis B surface antigen-positive recipients. Transpl
Infect Dis 2014; 16: 597-604.
21.- Shigemura N, Bhama J, Gries C J, Kawamu-
raT, Crespo M, Johnson B, et al. Lung transplan-
tation in Patients With Prior Cardiothoracic Surgical
Procedures. Am J Transplant 2012; 12: 1249-55.
22.- Fuehner T, Clajus C, Fuge J, Jonigk D, Wel-
te T, Haverich A, et al. Lung transplantation after
endoscopic lung volume reduction Respiration 2015;
90: 243-50.
23.- Singer J P, Blanc P D, Hoopes C, Golden J
A, Koff J L, Leard L E, et al. The impact of pre-
transplant mechanical ventilation on short-and long-
term survival after lung transplantation. Am J transplant
2011; 11: 2197-204.
24.- Fuehner T, Kuehn C, Hadem J, Wiesner O,
Gottlieb J, Tudorache I, et al. Extracorporeal
Membrane Oxygenation in Awake Patients as Bridge to
Lung Transplantation. Am J Respir Crit Care Med 2012;
185: 763-8.
25.- Chaikriangkrai K, Jyothula S, Jhun H J,
Estep J, Loebe M, Scheinin S, et al. Impact of
pre-operative coronary artery disease on cardiovascular
events following lung transplantation. J Heart Lung
Transplant 2016;35:115-21.
26.- Hayes D, Black S M, Tobias J D, Kirkby S,
Mansour H M, et al. Influence of Pulmonary Hyper-
tension on Patients With Idiopathic Pulmonary Fibrosis
Awaiting Lung Transplantation 2016; 101: 246-52.
27.- Hackman K L, BaileyM J, Snell G I, Bach L
A. Diabetes Is a Major Risk Factor for Mortality After
Lung Transplantation. Am J Transplant 2014; 14: 438-
45.
28.- Lyu D M, Zamora M R. Medical Complications of
Lung Transplantation. Proc Am Thorac Soc 2009; 6:
101-7.
29.- Miele C H, Schwab K, Saggar R, Duffy E,
Elashoff D, Tseng C H, et al. Lung Transplant
Outcomes in Systemic Sclerosis with Significant
Esophageal Dysfunction. A Comprehensive Single-
Center Experience. Ann Am Thorac Soc 2016; 13: 793-
802.
30.- Russo M J, IribarneA, Hong K N, Davies R R,
Xydas S, Takayama H, et al. High lung allocation
score is associated with increased morbidity and morta-
lity following transplantation. Chest 2010; 137: 651-7.
Rev Chil Enferm Respir 2017; 33: 37-46